
[trans(trans)]-4-pentyl-Cyclohexanecarboxylic acid 2,3-dicyano-1,4-phenylene ester | CAS:75414-73-2
[trans(trans)]-4-pentyl-Cyclohexanecarboxylic acid 2,3-dicyano-1,4-phenylene ester
- 名称:2,3-二氰基-1,4-亚苯基双([反式(反式)]-4-戊基-环己烷羧酸)酯 | [trans(trans)]-4-pentyl-Cyclohexanecarboxylic acid 2,3-dicyano-1,4-phenylene ester
- CAS号:75414-73-2
- 别名:
- 分子式:C32H44N2O4
- 分子量:520.70
- EINESC号:
产品描述
物理化学性质
密度 | 1.10±0.1 g/cm3 (20 ºC |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
The reaction of o?phthalaldchydic acid with 5?amino?1,3?dimethylpyrazole.Swett LR and Aynilian GH. Journal of Heterocyclic Chemistry, 12(6), 1135-1136 (1975)
A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression.Xuyi Yue et al.Organic & biomolecular chemistry, 13(29), 7928-7939 (2015-06-26)
1,3-Oxazines and related compounds. II.1) Ring contraction reaction of 1, 3-oxazin-4-one derivatives into 1,2,4-triazoles and pyrazoles.Yamamoto, et al. Chemical & Pharmaceutical Bulletin, 26(6), 1825-1831 (1978)
Anti-inflammatory and antinociceptive activities of LQFM002 - A 4-nerolidylcatechol derivative.E A Costa et al.Life sciences, 92(3), 237-244 (2013-01-09)
Discovery of new orally active phosphodiesterase (PDE4) inhibitors.Hiroshi Ochiai et al.Chemical & pharmaceutical bulletin, 52(9), 1098-1104 (2004-09-02)
The cyclocondensation of 5?amino?1,3?dimethylpyrazole with ethyl acetoacetate. Synthesis of isomeric pyrazolopyridones.Ratajczyk JD and Swett LR. Journal of Heterocyclic Chemistry, 12(3), 517-522 (1975)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!